Your password has been changed successfully.
|Please click here to Login with the new Password.|
OxyContin maker Purdue Pharma LP said on Saturday that it has cut its sales force in half and stop promoting opioids to physicians, following widespread criticism of the ways that drugmakers market addictive painkillers.“We have restructured and significantly reduced our commercial operation and will no longer be promoting opioids to prescribers,” the company said in a statement emailed to Reuters.After the job cuts, the company will have about 200 sales reps focused on promoting non-opioid products, the statement said.
A wave of lawsuits by states, counties and cities have accused drugmakers of pushing addictive painkillers through deceptive marketing and wholesale distributors of failing to report suspicious drug orders.
A group of state attorneys general have been conducting a multistate investigation into whether companies that manufacture and distribute prescription opioids engaged in unlawful practices.